BCL2 and breast cancer: cugWT1 is highly expressed in breast cancer cells, which can mediate tumor cell transformation and up-regulate c-MYC, BCL2, and EGFR expression; silencing it leads to decreased anchorage-independent growth and proliferation of breast cancer cells.